Intrathecal Administration of Levobupivacaine and Opioids in Elderly

NACompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2016

Conditions
Adverse Reaction to Spinal Anesthetic
Interventions
DRUG

The impact of 10 independent variables on the likelihood of not developing hypotension after intrathecal injection.

The study will be conducted to assess the impact of a 10 independent variables (dose and combination of Levobupivacaine with Fentanyl or Sufentanil, age, basal systolic blood pressure (SBP), basal mean arterial pressure (MAP), time to lowest spinal SBP, upper limit of sensory block (dermatoma level), time intervals of sensory recovery for two consecutive dermatoma level (two-segment regression), time intervals of sensory recovery to the twelfth thoracic dermatoma (T12 regression), time intervals of sensory recovery to the first sacral dermatoma (S1 regression) and Body Mass Index) on the likelihood of not developing hypotension after intrathecal injection.

Trial Locations (1)

10000

University Hospital Merkur, Zagreb

All Listed Sponsors
lead

Šarić, Jadranka Pavičić, M.D.

INDIV

NCT02385539 - Intrathecal Administration of Levobupivacaine and Opioids in Elderly | Biotech Hunter | Biotech Hunter